Thus, it has been proposed that while classical NF-κb activation plays a pro-inflammatory role in macrophages during early stages of tumor growth, in established tumors signals such as lymphotoxin, BAFF or CD40, can lead to alternative NF-κb activation (134). This evidence concerns the gene NFKB1 and neoplasm.